chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hands shaking and looked like she has Parkinson's; Blood pressure was 183 over something, which is high for her; Felt heart palpitations and pressure in her chest; Felt heart palpitations and pressure in her chest; Facial flushing, redness; Facial flushing, redness; Lips swollen and numb; Lips swollen and numb; Left arm stiffness; This is a spontaneous report from a contactable consumer reported for self. This 71-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 22Jan2021 12:30 on Arm left at single dose (lot number: EL8982) for Protection from COVID. Medical history included diabetes, slightly elevated blood pressure, taking drops under her tongue for her 21 environmental allergies, clarified product as sublingual immunotherapy, had a reaction to some kind of steroid shot recently. Had bad hives from it. Believes the steroid shot started with "met."  And allergy to antibiotic. Concomitant drug included Sublingual immunotherapy, metformin at 500 mg and cetirizine hydrochloride (ZYRTEC). Past drug history included had Drug hypersensitivity to Neurontin, Detrol, Sulfur, and Neuropherntin. The patient experienced facial flushing, redness, and her lips felt like she had a Novocain shot on 22Jan2021. Her lips are still kind of numb. Can't feel her lips when she bites down on them. Believes reaction was fairly immediate. Sitting there for 15-20 min. Could feel a little facial flushing. Went home because (name withheld) is 45 minutes away from her house. By the time she got home was very flushed. Lips were getting more swollen and numb on 22Jan2021. Had an Epinephrine injection UPS Auto injector 0.3 mg, NDC: 49502 10201,Lot: 9FM783, Exp: Jun2021, Dose: injected one time in the middle of her right thigh and used it. Went to the ER. Had blood work and an EKG done. Was kept for five hours in ER. Had a chest x-ray. Blood pressure was 183 over something, which is high for her on 22Jan2021 that is controlled with medication. Experienced Hands shaking and looked like she has Parkinson's on 22Jan2021. Only lasted for a short time. Put on Prednisone for five days and told to see primary physician. Can't get into primary physician until Wednesday. Felt heart palpitations and pressure in her chest. Can't separate if it was the COVID-19 Vaccine or her nerves. She experienced Left arm stiffness on 22Jan2021. AEs require a visit to ER, was discharged from ER. Lab data on 22Jan2021 included Two sets of blood work separated by 3-4 hours: Unknown Results, Chest X-ray: Unknown Results, EKG: normal; on unknown date had a colonoscopy the day before the COVID-19 Vaccine: Unknown Results; Treatments were received for the events. Outcome of the events was unknown.
A non-serious spontaneous report of administered to 13-month-old, fever of 102 and wheezing has been received from a respiratory therapy technician/father concerning his 13-month-old daughter, subsequent to H1H1, Intranasal. The patient had no past medical history or concomitant medications. The patient received H1N1, Intranasal on 21-Oct-2009 for an unknown indication. On 24-Oct-2009, the patient experienced fever of 102 and wheezing which resolved within 24 hours of their onset. These symptoms were mild. The patient was treated with albuterol inhaler on the day of the symptoms. Medical attention was not sought. The outcome of events was resolved. Additional information was received on 11-Nov-2009: information on patient's medical history, concomitant medications, adverse event information and outcome of the events.
Five minutes after receiving the vaccine, the patient slumped over in his chair, the pharmacist went out and shook him to wake him up. The patient was confused upon waking up. He became oriented approximately a minute after waking up. He was given water and sat in the chair for about another 10 minutes. His girlfriend came and picked him up and took him home. Patient stated he was feeling fine and has a history of fainting when receiving vaccines.
Resident received Covid Vaccine, noted after 30 mins with labored breathing BP 161/77, HR 116, R 38, T 101.4,
High grade fevers up to 104.0; shivers/rigors; unable to eat or drink 24-36 hours due to rigors; headache; eye aches/ eye movements painful; extensive drenching sweats x 3 days; head shakiness; dizziness; Body aches; This is a spontaneous report from a contactable Physician (patient). A 58-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: EL1283), intramuscular on left arm on 07Jan2021 12:15 at single dose for COVID-19 immunization. The patient's medical history was not reported. The patient had no known allergies. There were no concomitant medications. The previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730) on 19Dec2020 at 07:00 via intramuscular on left arm. No other vaccine in four weeks. On 07Jan2021 at 22:00, the patient had high grade fevers up to 104.0, shivers, rigors, headache, eye aches and eye movements painful, extensive drenching sweats for 3 days then slowed down, head shakiness and dizziness, unable to eat or drink 24-36 hours due to rigors. The patient reported that he experienced body aches, confined to bed 48 hours, then gradually and fully recovered by the end of day 4. No nausea or vomiting, and no cough. The patient took Acetaminophen 500mg x 1 oral (PO) as treatment to the events. No COVID prior vaccination. The patient was COVID tested post vaccination with 'POC test' (covid test type post vaccination=Nasal Swab) on 11Jan2021 which showed negative result. The outcome of the event body ache was recovered on 11Jan2021 and other events was recovered on unspecified date in Jan2021.
Upper arm red, swollen , hot, itching, and hard at injection site and painful at injection site.
pt recv vax 29JUL96 & 15OCT96 lab eval revealed VZV antibody titer 0.00 & pt failed to seroconvert a booster dose of varicella vaccine was given 28OCT96;
Incorrect Vaccine Administered. No signs or symptoms. No treatment indicated. No further action needed.
Minor soreness in the arm; A spontaneous report was received from a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and had minor soreness in his arm  The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 on 23 Dec 2020 intramuscularly for prophylaxis of COVID-19 infection. On 23 Dec 2020, the patient had a sore arm and did not take any medications.  He drank lots of water and noted that he always had minor soreness in the arm after every vaccine he has received.  On 24 Dec 2020, the event resolved.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, minor soreness in the arm, was resolved.; Reporter's Comments: This case concerns male patient of unknown age, who experienced a non-serious expected event of pain in arm. The event occurred at the same day of the first dose of mRNA-1273 vaccine. Patient reported drinking a lot of water and noted that he always had minor soreness in the arm after every vaccine he has received. The event resolved the day after.  The event was assessed as related to mRNA-1273 due to temporal association.
she took the 1st dose yesterday and she took Ibuprofen because her mind is clouded and her voice has changed; she took the 1st dose yesterday and she took Ibuprofen because her mind is clouded and her voice has changed; This is a spontaneous report from a contactable consumer or other non health care professional (patient). This is a report received from a Pfizer sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 19Feb2021 (Batch/Lot number and expiry date was not reported) as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that she took the 1st dose yesterday (19Feb2021) and she took ibuprofen because her mind was clouded and her voice had changed on an unspecified date in Feb2021. The clinical outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
The next morning after the vaccine I noticed a really red rash in my armpits. I didn't panic because I had a similar rash after taking some supplements last year; when I stopped taking them the rash went away within a week. I also have had a rash a few times after getting a flu shot similar to how this rash developed but not in the armpits and much lighter. PLEASE NOTE THAT I CANNOT ANSWER THE QUESTION ON THE NEXT PAGE -ITEM 22/23-ABOUT REACTIONS TO PREVIOUS FLU VACCINES.-I DO NOT HAVE THAT SPECIFIC INFORMATION. Within a day I had a full blown deep red 'ruby' rash from my armpits, down my sides, some between my breast and quite a bit down my back-like an hourglass from the top of my shoulders down to my sacrum. I did not go to the doctor, but called the pharmacist instead and got direction from him. That direction was to report the reaction to the Agency, my doctor and take BENADRYL if needed, which I did not take. It took about a week for the rash to go away. The next day after the vaccine I also had extreme fatigue and some chills which I undertand are normal. The pharmacist also said that I will need direction from the CDC and my doctor before I take the second vaccine, which will be after Jan. 12th.
Case previously recorded as MA2009-3333. Initial case report received from a physician via Med Com on 26 OCT 2009. A 2-year-old patient, was vaccinated with 0.5 ml S-OIV FLUVIRIN (batch no 100813-7P) i.m. on 24 OCT 2009. No adverse event was reported. Reference no. NA09-07008.
Patient had fever at beginning park of week, then broke out in bumps over body. Bumps scabbed over.
This spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown dates, the patients were vaccinated with RECOMBIVAX HB (lot # M037248, expiration date: 21-JUL-2017) for prophylaxis. According to the reporter, RECOMBIVAX HB was exposed to the following temperature excursions: 47 degrees Fahrenheit (F) to 77 F (71.5 F) for 57 hours, and 32 F to 35 F (33.5 F) for 166 hours. No adverse symptoms were reported. A digital data logger was involved. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1709USA010569: US-009507513-1709USA010754: US-009507513-1709USA010753.
w/in 10min of vax pt became diaphoretic & c/o severe h/a & intermittent vomiting;sx seem to come in waves;seen in ER about 4hr later;Phenergan suppository given & pt able to rest remainder of evening;
patient with pulse in 135, increase 150 and  She said was dry mouth, and have deep breaths. BP 176/97 mmhg. And call 911 She take wal-dryl, and put oxygen at 2 for 10 minutes
Information has been received through the pregnancy registry from a physician concerning a 35 year old female who on 6/1/2005 was vaccinated with a dose of varicella virus vaccine live (lot 648933/0827P). It was reported that the patient was definitely pregnant, with an LMP of 5/15/2005. Unspecified medical attention was sought. There was no product quality complaint involved. Follow up information received from a physician indicated that the patient was tested for varicella antibodies before vaccination, and the results were negative. It was noted that she had one previous pregnancy. No birth defects occurred in any previous pregnancy. No stillbirth or miscarriage occurred in any previous pregnancy. There was no local reaction at the vaccination site. There were no varicella or herpes zoster symptoms post vaccination. The reporter indicated that the patient lost the pregnancy in the first trimester. Upon internal review, the loss of pregnancy was considered to be an other important medical event (OMIC). No additional information is expected.
PRURITIS. Information has been received from a registered nurse concerning a female with a history of seasonal allergies who on 07-APR-2003 was vaccinated with hepatitis B virus vaccine rHBsAg (yeast) (0.5ml) (IM). Concomitant therapy included antihistamines. Subsequently, the patient "had itching with no rash the following day." The patient sought unspecified medical attention. Additional information has been requested.
Pt developed wheezing which progressively worsened (21yr hx of asthma). Seen by PMD x 2 who stated asthma was execarbated by the vaccine.
The level of Tinnitus discomfort in both ears worsened to extreme levels.  Additional symptoms included loss of balance, sleeplessness, and difficulty in concentration.  Over succeeding weeks the symptoms improved, however the Tinnitus remains at a higher level than before the COVID shot and sleeplessness continues.  I had Tinnitus prior to COVID shots, but it was manageable.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On an unknown date, an expired sterile diluent (dose, frequency, route of administration, lot# and expiration date were not reported) was used to reconstitute (Oka/Merck) VARIVAX (dose, frequency, route of administration, lot# and expiration date were not reported) and was inadvertently administered to a patient. No adverse effects were reported. Product quality complaint (PQC) was not involved. Additional information has been requested.
Late night insomnia, agitation, restlessness, anxiety (awake between 3-6AM with racing thoughts); Able to fall asleep at normal bedtime; THC, CBD, melatonin 6mg ineffective; Benadryl partially effective.
Patient became weak and woozy. He lost color in his face. This lasted for fifteen minutes and he began to feel better. No treatment required.
Extreme Chills Body Aches Fever Severe Headache Fatigue Nausea
She even had an elevated D dimer test with no PE on VQ scan.  She is slowly improving but continues to have some chest tightness with deep breaths.
Patient is a 17 -year-old-dependent male with no significant past medical history who presents to Healthcare Office by referral from his primary care provider for further evaluation and management of an adverse event following immunizations. Patient, who was  accompanied to  the clinic by his mother, describes receiving four vaccination  on 30 August 2016 (MCV 4, MMRV.,  Tdap  and IPV) as described below who initially did well without any immediate adverse reactions. However, just over 2 weeks later, the patient began to develop significant myalgias, arthralgias, fatigue, malaise, as well as associated dyspnea and sore throat. On the morning of 19 September 2016 the patient awoke with significantly worse symptoms and his mother took  him to the emergency department. Evaluation at that time revealed a significant neutropenia with an ANC of 100. The patient was admitted to the hospital for neutropenia and a workup was initiated. Patient denies any significant drug/medication use other than vaccines described above. Patient denies any international travel. He denies any other recent preceding infections. Workup while hospitalized included viral cultures, HIV serology, EBV titers, Monospot, CMP, influenza A.  and B.  testing, and rickettsial titers which were all essentially negative/within normal limits. Patient was referred to our clinic for further consideration of vaccine-induced neutropenia. Patient denies any previous adverse reactions to vaccines.
On 3/10 I woke up with a rash on the arm where I had the injection.  About 6:00 that evening I felt a tingling sensation in my upper lip.  As the evening progressed it seemed to start to swell.  About 9:00 my throat started to feel as though it was closing. I took 50 mg of Benadryl.  We went to the hospital and my blood pressure was 180/81.  They gave me an IV with Benadryl, Prednisone and Pepcid.  I was released about 1:00 with a prescription for Prednisone for 5 days.
did not feel well; bit of a flu; run down; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well), INFLUENZA (bit of a flu), FEELING ABNORMAL (run down) and PAIN IN EXTREMITY (Sore arm) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 013L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (COVID-19 1.5 years ago).   On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Aug-2021, the patient experienced MALAISE (did not feel well), INFLUENZA (bit of a flu), FEELING ABNORMAL (run down) and PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 30-Aug-2021, MALAISE (did not feel well), INFLUENZA (bit of a flu) and FEELING ABNORMAL (run down) had resolved. On 02-Sep-2021, PAIN IN EXTREMITY (Sore arm) had resolved.            No concomitant medication was reported. After the first booster dose of the vaccine the patient had a sore arm the day after and did not feel well. For 1 day the patient felt run down and had a bit of a flu. The patients sore arm lasted 3 days before resolving.   This case was linked to MOD-2022-542616 (Patient Link).
experienced flu-like symptoms following the second dose of Shingrix; headache; chills; fatigue; nausea; muscle soreness; fever; This case was reported by a consumer via sales rep and described the occurrence of influenza-like symptoms in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of myalgia (received 1st dose on unknown date and had muscle soreness, refer case US2019AMR221202.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than a day after receiving Shingrix, the patient experienced influenza-like symptoms, headache, chills, fatigue, nausea, muscle soreness and fever. The patient was treated with ibuprofen (Advil) and sumatriptan (Imitrex Tablet). Rechallenge with Shingrix was positive. On an unknown date, the outcome of the influenza-like symptoms, headache, chills, fatigue, nausea, muscle soreness and fever were unknown.   It was unknown if the reporter considered the influenza-like symptoms, headache, chills, fatigue, nausea, muscle soreness and fever to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. Within 8 hours after vaccination, the patient experienced  flu-like symptoms, which was including headache, fatigue, muscle soreness, chills, fever and nausea. Other medications had taken since the shot included advil for muscle soreness and Imitrex tablet for the headache.
10 PM on day of vaccine-significant shivers and shaking lasting until about 6 a.m. next morning.  Fitful sleep. Very lethargic lasting until late afternoon around 3 p.m.  Had woke up with headache behind forehead.  Took 2  store brand pain reliever (naproxen sodium 220 mg. and naproxen 200 mg.) at 11 a.m. Headache subsided about 3 p.m.  Slight nausea during the day (Nov. 24th) and little appetite lasting into the afternoon of Nov. 25th.
I was supposed to start my menstrual cycle two days after receiving vaccine but never did.  I still haven?t had one and I?m not pregnant.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Feb2021 as dose 1, single (Lot number: EN6198), in left arm, on 19Mar2021 as dose 2, single (Lot number: EN628), in left arm, on 01Oct2021 as dose 3 (booster), single (Lot number: 301358A), in left arm and on 01Apr2022 as dose 4 (booster), single (Lot number: FM0698) at the age of 69 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 09Sep2022 at 10:30 as dose 5 (booster), single (Lot number: AS7144B), in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: steriods - red face" (unspecified if ongoing), notes: other medical history: No - healthy. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "recovered" (28Nov2022) and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of covid-19.
injection site arm was sore for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (injection site arm was sore for 3 days) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced INJECTION SITE PAIN (injection site arm was sore for 3 days). On 18-Mar-2021, INJECTION SITE PAIN (injection site arm was sore for 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. No treatment medication was reported.   This case was linked to MOD-2022-496059 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2022: Live Follow-up received contains no new information.
loss of taste; loss of smell; This is a spontaneous report from a contactable consumer (patient). A 35-year-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EN6206),  via an unspecified route of administration, administered in left arm on 10Mar2021 07:00 (at the age of 35-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine and other medications within two weeks to the COVID vaccine was NA. The patient did not have COVID prior vaccination, and the patient had tested for Covid-19, post vaccination. The patient experienced loss of taste and loss of smell on 12Mar2021 09:00. The patient underwent lab tests and procedures which included (Nasal Swab) sars-cov-2 antibody test: negative on 12Mar2021. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive treatment for the adverse events. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
got "shingles"/ Small patch but uncomfortable; Small patch; Small patch but uncomfortable; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (first dose of shingles vaccine received seven years ago).   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 24 hrs after receiving Shingrix, the patient experienced shingles, patchy rash and discomfort. On an unknown date, the outcome of the shingles, patchy rash and discomfort were unknown.   It was unknown if the reporter considered the shingles, patchy rash and discomfort to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient reported that received first dose of shingles vaccine seven years ago and was fine. Then patient received dose of Shingrix vaccine and got shingles 24 hours later small patch but uncomfortable.